IFG Advisory
TEVA icon

IFG Advisory’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

IFG Advisory’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.7K Buy
374
+24
+7% +$799 ﹤0.01% 1775
2026
Q1 		$10.5K Buy
+350
New +$11.3K 0.03% 242

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return

IFG Advisory's TEVA Position: Q2 2026 in Review

IFG Advisory increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 6.9% in Q2 2026, buying an estimated $799 and bringing the position to 374 shares worth $12.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1775.

IFG Advisory first reported a position in TEVA in Q1 2026 and has held it in 2 quarters since. 677 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • IFG Advisory held 374 shares of Teva Pharmaceutical Industries Limited worth $12.7K as of Q2 2026.
  • IFG Advisory bought 24 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $799.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of IFG Advisory's portfolio in Q2 2026, its #1775 holding.
  • IFG Advisory first reported a position in Teva Pharmaceutical Industries Limited in Q1 2026 and has held it in 2 quarters since.
  • 677 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on IFG Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.